Kinnevik is a leading growth investor founded in 1936, providing patient capital to challenger technology-enabled businesses across Europe and the US. The firm operates as an active owner and operational partner, investing at all stages of a company's growth journey from early-stage through growth equity. Kinnevik focuses on three core sectors: healthcare, software, and climate, backing passionate founders building tomorrow's leaders that make everyday life easier and better for people around the world. With a net asset value of approximately SEK 29.6 billion and a portfolio of over 20 larger investees, Kinnevik has distributed SEK 87.7 billion in value since 2018. The firm maintains offices in Stockholm and London, taking a long-term approach to value creation. Recent investments include Tandem Health's €86.5 million round, Mews' €264 million funding, and Oviva in European healthcare.

Profile auto-generated from public sources — details unverified.